Nuveen, LLC Sc Pharmaceuticals Inc. Transaction History
Nuveen, LLC
- $363 Billion
- Q3 2025
A detailed history of Nuveen, LLC transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Nuveen, LLC holds 85,940 shares of SCPH stock, worth $487,279. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85,940
Previous 76,151
12.85%
Holding current value
$487,279
Previous $290,000
67.59%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SCPH
# of Institutions
118Shares Held
40.4MCall Options Held
835KPut Options Held
173K-
Orbimed Advisors LLC San Diego, CA6.06MShares$34.4 Million1.17% of portfolio
-
Rubric Capital Management LP New York, NY5.1MShares$28.9 Million0.47% of portfolio
-
Weiss Asset Management LP Boston, MA2.88MShares$16.3 Million0.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$12.3 Million0.0% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX2.13MShares$12.1 Million0.05% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $155M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...